These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1470207)

  • 1. Microdialysis in the study of psychostimulants and the neural substrate for reinforcement: focus on dopamine and serotonin.
    Hoebel BG; Hernandez L; Mark GP; Pothos E
    NIDA Res Monogr; 1992; 124():1-34. PubMed ID: 1470207
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin and behavior: a brief summary.
    Aprison MH; Hingtgen JN
    Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between serotonergic and catecholaminergic systems in the brain.
    Kostowski W
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):15-24. PubMed ID: 1107968
    [No Abstract]   [Full Text] [Related]  

  • 4. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
    Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral contingencies involved in drug-induced neurotransmitter turnover changes.
    Dworkin SI; Smith JE
    NIDA Res Monogr; 1986; 74():90-106. PubMed ID: 2892137
    [No Abstract]   [Full Text] [Related]  

  • 6. Conditioned dopaminergic activity.
    Schiff SR
    Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 9. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of behavioral controls in the analysis of ongoing events.
    Dworkin SI; Porrino LJ; Smith JE
    NIDA Res Monogr; 1992; 124():173-88. PubMed ID: 1470211
    [No Abstract]   [Full Text] [Related]  

  • 11. There is more to dopamine than just pleasure. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Lingford-Hughes A
    Behav Pharmacol; 2002 Sep; 13(5-6):367-70. PubMed ID: 12394412
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acute and chronic tri-iodothyronine (T3) administration to rats on central 5-HT and dopamine-mediated behavioural responses and related brain biochemistry.
    Atterwill CK
    Neuropharmacology; 1981 Feb; 20(2):131-44. PubMed ID: 7193809
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug seeking: a behavioral analysis in animals and humans.
    Fischman MW; Schuster CR
    NIDA Res Monogr; 1978 Jul; (20):4-23. PubMed ID: 101859
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonergic mechanisms in the brain: a model for the integrative investigation of behavior and psychopharmacology.
    Sass H
    Pharmacopsychiatry; 1995 Oct; 28 Suppl 2():45-6. PubMed ID: 8614700
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotine addiction: insights from recent animal studies.
    Mathieu-Kia AM; Kellogg SH; Butelman ER; Kreek MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):102-18. PubMed ID: 12110988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine, reinforcement learning, and addiction.
    Dayan P
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S56-65. PubMed ID: 19434556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings].
    Marsden CA
    Br J Pharmacol; 1978 Nov; 64(3):431P. PubMed ID: 719281
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral neurochemistry of benzodiazepines.
    Stein L
    Arzneimittelforschung; 1980; 30(5a):868-73. PubMed ID: 6106487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of substance P and its fragments: analgesic properties, effect on behavior and monoaminergic processes].
    Klusha VE; Abissova NA; Mutsenietse RK; Svirskis ShV; Binert M
    Biull Eksp Biol Med; 1981 Dec; 92(12):692-4. PubMed ID: 6173081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural systems implicated in delayed and probabilistic reinforcement.
    Cardinal RN
    Neural Netw; 2006 Oct; 19(8):1277-301. PubMed ID: 16938431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.